Follow us
Contact us
Beta version
for any comments please
contact us
Daily News
Editorials
WoCo
Skin Cancer
TASCDerm
About
TASCDerm Post
Name & Affiliation
TASCDerm Category
injectables
platelet-rich-plasma
threads
Name and affiliation
Study title
please cut and paste the study title
Abstract link to Pub Med or directly to the journal
In the case of an open access article, please cut and paste the link
Randomization
0
1
2
Placebo
0
1
2
Blinding
0
1
2
Objective measurement
0
1
Sample size more than 21
0
1
Sample selection and allocation concealment
0
1
Economical
0
1
Conflict of interest
0
1
Withdrawal / Dropouts
0
1
Coherent endpoints & assessment times
0
1
Co-Interventions
0
1
Acceptable theory
0
1
Comment from the submitter
Submitter email (your email will not be visible to others)
Google Captcha
TASCDerm Criteria explanations
Randomization (2)
0 if no randomization performed or not mentioned, 1 if partial or inadequate, 2 if adequate
Placebo (2)
0 if no placebo, 1 if inert placebo, 2 if compared to gold standard.
Blinding (2)
0 No blinding, 1 Single blinded, 2 Double blinded
Objective measurement (1)
Example: 1 if Colorimeter is used for melasma and 0 if MASI is used.
Sample size more than 21 (1)
Effect size of 0.5, alpha 0.05 and power 80
Sample selection and allocation concealment (1)
0 if study is done on clinic staff or if person knows allocated group. 1 if appropriate.
Economical (1)
1 if intervention cheaper than gold standard
Conflict of interest (1)
0 if present, 1 if absent
Withdrawal / Dropouts (1)
0 if more than 1 in 5 (20%) or not mentioned, 1 if not
Coherent endpoints & assessment times (1)
0 if not mentioned or inappropriate, 1 if appropriate
Co-Interventions (1)
0 if multiple active ingredients tested, 1 if single
Acceptable theory (1)
0 if no rational theoretical basis, 1 if sound
If a criteria is not mentioned in the publication, the criteria is not scored and gets 0